A Multicentre, Open-Label, Nonrandomised, Non-Interventional, Observational Study to Compare Safety and Effectiveness of Biphasic Insulin Aspart 30 (NovoMix 30) and Insulin Detemir (Levemir) for the Treatment of Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Acronyms SAFE
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 30 Oct 2009 Actual patient number (2589) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.